Tissue Engineering Global Market Outlook 20172023 [Report Updated: 01112017] Prices from USD $4150

09:11 EST 4 Feb 2018 | BioPortfolio Reports

According to Stratistics MRC, the Global Tissue Engineering market is expected to grow from $7.06 billion in 2016 to reach $16.82 billion by 2023 with a CAGR of 13.2%. Growing usage of tissue engineering as an alternative for organs is the major factor propelling the market growth. In addition, recent technological advancements, encouraging government initiatives, and huge investments in RD are the some of the key factors fostering the market growth. On the other hand, strict regulations for approvals, time taking process to develop a tissue high costs are the constraints limiting the market growth.

Among all the applications, orthopedic segment leads the market globally with the biggest market share and is expected to grow with a higher CAGR during the forecast period. The growth of this segment is attributed to growing geriatric population and raising incidence of reconstructive and replacement surgeries. Neurology segment is likely to witness faster growth rate due to increasing research development. North America is emerged as the major revenue generating region in the global market due to innovative technological developments, and increasing incidence of cancer rates in the Canada and U.S. Asia Pacific is expected to witness high growth rate during the forecast period.

Some of the key players in global tissue engineering market include Acelity, CryoLife, ReproCell Inc., Stryker Corporation, Medtronic Inc., Integra LifeSciences, RTI Surgical Inc., Acell Inc, Organogenesis Inc, Zimmer Biomet, Athersys Inc, Sanofi, AastromBioSciences, BioMemetic Therapeutics, Tissue Regenix Group Plc, and Advanced Cell Technology.

Applications Covered:

Orthopedics, musculoskeletal and spine

Cardiology vascular



Cord blood cell banking

GI gynecology




Other Applications

Regions Covered:

North America

o US

o Canada

o Mexico


o Germany

o UK

o Italy

o France

o Spain

o Rest of Europe

Asia Pacific

o Japan

o China

o India

o Australia

o New Zealand

o South Korea

o Rest of Asia Pacific

South America

o Argentina

o Brazil

o Chile

o Rest of South America

Middle East Africa

o Saudi Arabia


o Qatar

o South Africa

o Rest of Middle East Africa

What our report offers:

Market share assessments for the regional and country level segments

Market share analysis of the top industry players

Strategic recommendations for the new entrants

Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets

Market Trends Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations

Strategic recommendations in key business segments based on the market estimations

Competitive landscaping mapping the key common trends

Company profiling with detailed strategies, financials, and recent developments

Supply chain trends mapping the latest technological advancements

Original Article: Tissue Engineering Global Market Outlook 20172023 [Report Updated: 01112017] Prices from USD $4150


More From BioPortfolio on "Tissue Engineering Global Market Outlook 20172023 [Report Updated: 01112017] Prices from USD $4150"

Quick Search

Relevant Topics

Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...